Is medical affairs the Ferrari of the pharma industry? - European Medical Journal

Is medical affairs the Ferrari of the pharma industry?

EMJ GOLD

Season 04: episode 04

This week, it’s fantastic to welcome one of our regular contributors, Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS, to The GOLD Podcast studio to discuss all things medical affairs.

In his own words, “pharmaceutical organisations have a Ferrari in their multi-car garage and they are driving it to do the grocery shopping”, and Isabel was intrigued to find out more about the value of medical affairs and why Bora believes it isn’t being utilised effectively.

But that’s not all. Tune in to listen to Bora’s thoughts on how the function can better meet the needs of healthcare professionals and what skills the future MA workforce will need to succeed.

A little more on GOLD’s guest…

Bora Erdemli is Associate Principal and Leader of Medical Affairs Practice, Europe, ZS. While now a specialist in medical affairs, he has a background in engineering and holds a PhD in Biophysics from the Johns Hopkins University School of Medicine. In his work at ZS, Bora focuses on helping companies create winning medical affairs strategies across data and evidence generation, insight activities and more. He is also a member of the Medical Affairs Professional Society (MAPS) in which he co-leads the Nordics and Switzerland chapter.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>